17-35440852-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_144682.6(SLFN13):c.2437G>A(p.Val813Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,614,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V813F) has been classified as Uncertain significance.
Frequency
Consequence
NM_144682.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152178Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251418 AF XY: 0.0000662 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461856Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 727224 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74448 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2437G>A (p.V813I) alteration is located in exon 6 (coding exon 4) of the SLFN13 gene. This alteration results from a G to A substitution at nucleotide position 2437, causing the valine (V) at amino acid position 813 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at